Biosimilar Clinical Development

Biosimilar Clinical Development

by Barker, Kerry B.

Type Book
Rate 0.0 /5

Cover -- Half Title -- Title Page -- Copyright Page -- Contents -- Preface -- Editors -- Contributors -- 1. Biosimilars for Drug Development: The Time Is Now! -- 2. From Isolation to Integration: A Systems Biology Approach for the Discovery of Therapeutic Targets and Biomarkers -- 3. Immunogenicity of Biological Products: Current Perspectives and Future Implications -- 4. Interchangeability between Biosimilar and Innovator Drug Products -- 5. Bridging a New Biological Product with Its Reference…

Read More ↓

Title Statements

  • Full title :Biosimilar Clinical Development

Summary

Cover -- Half Title -- Title Page -- Copyright Page -- Contents -- Preface -- Editors -- Contributors -- 1. Biosimilars for Drug Development: The Time Is Now! -- 2. From Isolation to Integration: A Systems Biology Approach for the Discovery of Therapeutic Targets and Biomarkers -- 3. Immunogenicity of Biological Products: Current Perspectives and Future Implications -- 4. Interchangeability between Biosimilar and Innovator Drug Products -- 5. Bridging a New Biological Product with Its Reference Product -- 6. Accounting for Covariate Effect to Show Noninferiority Biosimilars

7. Novel Method in Inference of Equivalence in Biosimilars -- 8. Multiplicity Adjustments in Testing for Bioequivalence -- 9. Bayesian Methods to Assess Bioequivalence and Biosimilarity with Case Studies -- 10. Average Inferiority Measure and Standardized Margins to Address the Issues in Biosimilar Trials -- 11. Bayesian Methods for Design and Analysis of Noninferiority Trials -- Index

Read More ↓

Edition Statements

  • Publication Date:2016

Publication Statements

  • Publisher(s):CRC Press
  • Place of Publication:Boca Raton
  • Language:eng
  • Publication Date:2016

Notes

IMD-Felder maschinell generiert

The Physical Object

  • Description:1 Online-Ressource (269 Seiten)

Edition Identifiers

  • ISBN:9781315355900, 1315355906, 9781482231694, 1482231697
  • oclc:on1020854202
  • LC Classification:RS162.B5612 2017

Writers

More from this Series

  • Measures of interobserver agreement and reliability

    2011.
    more →
    Measures of interobserver agreement and reliability
  • Monte Carlo simulation for the pharmaceutical industry

    2011.
    more →
    Monte Carlo simulation for the pharmaceutical industry
  • Frailty models in survival analysis

    2011.
    more →
    Frailty models in survival analysis
  • Quantitative Evaluation of Safety in Drug Development

    2014
    more →
    Quantitative Evaluation of Safety in Drug Development
  • Noninferiority testing in clinical trials

    2015
    more →
    Noninferiority testing in clinical trials

Rate & Review

0.0/5
(0 people Voted)

No reviews yet. Be the first to rate this work.

Files & Downloads

  • Biosimilar Clinical Development: Scientific Consi…

    PDF · 3.4 MB · updated
  • Biosimilar clinical development: scientific consi…

    PDF · 5.4 MB · updated